Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERIBULIN vs ESCITALOPRAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERIBULIN vs ESCITALOPRAM: Safety Overview

Metric ERIBULIN ESCITALOPRAM
Total FAERS Reports 5,055 402
Deaths Reported 793 73
Death Rate 15.7% 18.2%
Hospitalizations 2,642 139
Average Patient Age 57.3 yrs 49.8 yrs
% Female Patients 93.0% N/A
FDA Approval Date Apr 5, 2024 N/A
Manufacturer Gland Pharma Limited N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A